Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001345281-23-000005
Filing Date
2023-11-16
Accepted
2023-11-16 13:49:12
Documents
1
Period of Report
2023-03-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 5722
  Complete submission text file 0001345281-23-000005.txt   7437
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 E 9TH ST 2K NEW YORK NY 10003
Business Address 40 E 9TH ST 2K NEW YORK NY 10003 6462620663
Edward Gerald Kay Estate (Reporting) CIK: 0002000481 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31668 | Film No.: 231413925